Your browser doesn't support javascript.
loading
Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial.
Hatooka, Masahiro; Kawaoka, Tomokazu; Aikata, Hiroshi; Inagaki, Yuki; Morio, Kei; Nakahara, Takashi; Murakami, Eisuke; Tsuge, Masataka; Hiramatsu, Akira; Imamura, Michio; Kawakami, Yoshiiku; Awai, Kazuo; Masaki, Keiichi; Waki, Koji; Kohno, Hirotaka; Kohno, Hiroshi; Moriya, Takashi; Nagaoki, Yuko; Tamura, Toru; Amano, Hajime; Katamura, Yoshio; Chayama, Kazuaki.
Afiliação
  • Hatooka M; Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, 734-8551, Japan.
  • Kawaoka T; Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, 734-8551, Japan.
  • Aikata H; Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, 734-8551, Japan. aikata@hiroshima-u.ac.jp.
  • Inagaki Y; Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, 734-8551, Japan.
  • Morio K; Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, 734-8551, Japan.
  • Nakahara T; Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, 734-8551, Japan.
  • Murakami E; Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, 734-8551, Japan.
  • Tsuge M; Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, 734-8551, Japan.
  • Hiramatsu A; Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, 734-8551, Japan.
  • Imamura M; Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, 734-8551, Japan.
  • Kawakami Y; Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, 734-8551, Japan.
  • Awai K; Department of Diagnostic Radiology, Graduate School of Biomedical Sciences, Hiroshima, 734-8551, Japan.
  • Masaki K; Hiroshima City Asa Hospital, Hiroshima, Japan.
  • Waki K; Hiroshima City Asa Hospital, Hiroshima, Japan.
  • Kohno H; Kure Medical Center, Hiroshima, Japan.
  • Kohno H; Kure Medical Center, Hiroshima, Japan.
  • Moriya T; Chugoku Rousai Hospital, Hiroshima, Japan.
  • Nagaoki Y; Mazda Hospital, Hiroshima, Japan.
  • Tamura T; Mazda Hospital, Hiroshima, Japan.
  • Amano H; Onomichi General Hospital, Hiroshima, Japan.
  • Katamura Y; Onomichi General Hospital, Hiroshima, Japan.
  • Chayama K; Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science, Hiroshima University, Hiroshima, 734-8551, Japan.
BMC Cancer ; 18(1): 633, 2018 Jun 04.
Article em En | MEDLINE | ID: mdl-29866075

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infusões Intra-Arteriais / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Hepatocelular / Sorafenibe / Neoplasias Hepáticas Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infusões Intra-Arteriais / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Hepatocelular / Sorafenibe / Neoplasias Hepáticas Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão